Showing results (2031-2040 of 4,129) with videos related to
Sort By:
Pageof 413
Journal of Acquired Immune Deficiency Syndromes|September 1, 1993
Response of human immunodeficiency virus-infected adults to measles-rubella vaccinationM A Sprauer, L E Markowitz, J K Nicholson, et al.The Journal of Urology|January 1, 1993
Surgery following response to interferon-alpha-based therapy for residual renal cell carcinomaA Sella, D A Swanson, J Y Ro, et al.Cancer Research|August 5, 2008
Ugene, a newly identified protein that is commonly overexpressed in cancer and binds uracil DNA glycosylaseChunguang Guo, Xiaodong Zhang, Stephen P Fink, et al.American Journal of Epidemiology|November 29, 2001
Evaluation of an early two-dose measles vaccination scheduleS S Hutchins, A Dezayas, K Le Blond, et al.Anesthesiology|August 10, 2002
Dexamethasone in combination with dolasetron for prophylaxis in the ambulatory setting: effect on outcome after laparoscopic cholecystectomyMargarita Coloma, Paul F White, Scott D Markowitz, et al.Molecular Genetics and Metabolism|November 25, 2011
START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patientsJeanine R Jarnes Utz, Cindy Pham Lorentz, Dorothy Markowitz, et al.The Journal of Infectious Diseases|April 14, 2000
The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapyJ M Binley, D S Schiller, G M Ortiz, et al.American Journal of Epidemiology|April 27, 2001
Incidence of herpes simplex virus type 2 infection in the United StatesG L Armstrong, J Schillinger, L Markowitz, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2005
Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trialGershon Frisch, Julie Lin, Jordan Rosenstock, et al.Journal of Clinical Microbiology|June 21, 2013
A consortium of Aggregatibacter actinomycetemcomitans, Streptococcus parasanguinis, and Filifactor alocis is present in sites prior to bone loss in a longitudinal study of localized aggressive periodontitisDaniel H Fine, Kenneth Markowitz, Karen Fairlie, et al.Pageof 413